Last updated: 11/03/2018 20:55:58
This product has been transferred to Novartis. GSK Clinical Study Register is no longer maintained for this study.

Monitoring biomarkers linked to immunosuppression during VEG113046 to predict clinical response to pazopanib and to demonstrate immunostimulatory properties of this molecule

GSK study ID
200707
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
No longer a GSK study
No longer a GSK study
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: Monitoring biomarkers linked to immunosuppression during VEG113046 to predict clinical response to pazopanib and to demonstrate immunostimulatory properties of this molecule
Trial description: Monitoring biomarkers linked to immunosuppression during VEG113046 to predict clinical response to pazopanib and to demonstrate immunostimulatory properties of pazopanib being conducted at the Georges Pompidou Hospital in Paris, Fance.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:

PBMC biomarker samples

Timeframe: Obtained during the VEG113046 study

Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
108
Primary completion date:
Not applicable
Observational study model:
Other
Time perspective:
Retrospective
Clinical publications:
Not applicable
Medical condition
Carcinoma, Renal Cell
Product
pazopanib
Collaborators
Not applicable
Study date(s)
October 2011 to August 2015
Type
Observational
Phase
3

Participation criteria

Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
none
  • Per VEG113046 study
  • Per VEG113046 study
Inclusion and exclusion criteria
Inclusion criteria:
  • Per VEG113046 study
Exclusion criteria:
  • Per VEG113046 study

Trial location(s)

This study does not involve prospective enrollment of participants.

Study documents

No study documents available.

Results overview

No study documents available

Recruitment status
No longer a GSK study
Actual primary completion date
Not applicable
Actual study completion date
2015-12-08

Plain language summaries

Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.

Additional information about the trial

Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website